FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to endocrinology and cardiology, and can be used to predict the risk of developing multivessel coronary artery disease in individuals with type 2 diabetes mellitus. Whole blood is examined for polymorphisms of the vitamin D receptor (VDR) gene: FokI, BsmI, TagI. If there is a combination of the genotype TT of the polymorphic marker TagI with the genotype ff of the polymorphic marker FokI, or the combination of the genotype TT or Tt of the polymorphic marker TagI with the genotype FF or Ff of the polymorphic marker Fokl and the genotype BB or Bb of the polymorphic marker BsmI, the risk of developing multivessel coronary artery disease in type 2 diabetes mellitus is predicted.
EFFECT: method provides more effective prediction of developing multivessel coronary artery disease in patients with type 2 diabetes mellitus by determining polymorphisms FokI, BsmI, TagI of the VDR gene in blood.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF POSTPARTUM OSTEOPENIC SYNDROME | 2013 |
|
RU2558094C1 |
| METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2017 |
|
RU2670689C9 |
| METHOD OF PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR ANEURYSM IN PATIENTS AFTER MYOCARDIAL INFARCTION, TAKING INTO ACCOUNT GENETIC FACTORS | 2022 |
|
RU2801684C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE CARDIOVASCULAR EVENTS WITHIN A YEAR AFTER CORONARY ARTERY BYPASS SURGERY | 2020 |
|
RU2731305C1 |
| METHOD FOR DETECTION OF GENETIC PREDISPOSITION TO DEVELOPING MYOCARIAL INFARCTION IN INDIVIDUALS WITH NO CLINICAL IMPLICATIONS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2469096C2 |
| METHOD FOR PREDICTION OF METABOLIC SYNDROME RISK WITH UNDERLYING ANTIPSYCHOTIC THERAPY IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2722649C1 |
| METHOD FOR PREDICTION RISK OF DEVELOPMENT OF DIABETIC ANGIOPATHY OF LOWER EXTREMITIES IN PATIENTS SUFFERING TYPE 2 DIABETES MELLITUS | 2012 |
|
RU2507520C1 |
| GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS | 2015 |
|
RU2703192C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF TYPE 2 DIABETES MELLITUS IN BASHKORTOSTAN POPULATION | 2018 |
|
RU2688208C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH OVERWEIGHT OR OBESITY | 2024 |
|
RU2834146C1 |
